Institutional Relations
Cultivating durable engagement with public authorities, regulators, and industry bodies across jurisdictions.
— Strategic Pharmaceutical Advisory
Connecting the European pharmaceutical industry to South America’s strategic markets.
Strategic advisory, institutional relations, regulatory intelligence, and business development for international pharmaceutical operations.
EuropeSouth America
01 / About
A strategic bridge between regulated markets.
Mosel Taquari Limited is an institutional advisory firm dedicated to facilitating sophisticated relationships between the European pharmaceutical industry and the strategic markets of South America, with particular focus on Brazil.
Our practice combines deep regional regulatory expertise, multilateral institutional networks, and a discreet, diplomatic approach to building the long-term relationships required to operate successfully in complex pharmaceutical environments.
20+
Years of cumulative regulatory experience
Europe ⇄ LATAM
Cross-jurisdictional advisory
02 / Strategic Services
Advisory practices built for regulated, high-stakes environments.
Regulatory Intelligence
Continuous monitoring and interpretation of pharmaceutical regulation in Brazil and South American markets.
Business Development
Identifying and structuring partnerships, licensing, and distribution opportunities aligned with strategic priorities.
Public Affairs
Positioning corporate interests within institutional dialogue with measured, evidence-based advocacy.
Market Entry Strategy
Designing tailored entry pathways with rigorous assessment of regulatory, commercial, and political variables.
Executive Advisory
Confidential counsel for senior leadership navigating expansion, regulatory transition, and stakeholder management.
03 / Approach
Strategic relationships require precision, context, and institutional trust.
We operate as a discreet extension of our clients’ leadership — measured in tone, rigorous in method, and unwavering in confidentiality.
Europe – Brazil
Specialised expertise in the regulatory and institutional dynamics linking both regions.
Pharmaceutical depth
Sector-focused practice with technical literacy across the value chain.
Institutional engagement
Established channels with public, private, and multilateral stakeholders.
Compliance & confidentiality
Strict standards governing every interaction and engagement.
04 / Process
A measured methodology, refined for institutional outcomes.
- I
Strategic assessment
Comprehensive evaluation of objectives, regulatory landscape, and stakeholder environment.
- II
Institutional mapping
Identification of relevant authorities, partners, and decision-making structures.
- III
Relationship building
Considered cultivation of trust with the institutional actors central to the mandate.
- IV
Regulatory execution
Coordinated execution of regulatory and institutional workstreams under defined governance.
- V
Ongoing advisory
Continuous monitoring, advisory support, and strategic recalibration as the environment evolves.
05 / Contact
Schedule a strategic conversation.
All interactions are conducted with discretion and institutional alignment.
- Office
- London, United Kingdom
- Correspondence
- richard.back@moseltaquarilimited.uk